Aquilo Capital Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Aquilo Capital Management, LLC

$100 Million
Q2 2024

A detailed history of Aquilo Capital Management, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Aquilo Capital Management, LLC holds 908,474 shares of ARWR stock, worth $18.2 Million. This represents 23.61% of its overall portfolio holdings.

Number of Shares

908,474

Previous 908,474 -0.0%

Holding current value

$18.2 Million

Previous $26 Million 9.13%

% of portfolio

23.61%

Previous 20.27%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$26.2 - $36.08 $1.31 Million - $1.8 Million	50,000 Added 5.82%	908,474 $24.4 Million
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $4.03 Million - $6.62 Million	-160,000 Reduced 15.71%	858,474 $30.6 Million
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $2.01 Million - $3.27 Million	-85,041 Reduced 7.71%	1,018,474 $25.9 Million
Q4 2022 Feb 14, 2023	SELL	$28.0 - $40.56 $3.22 Million - $4.66 Million	-115,000 Reduced 9.44%	1,103,515 $44.8 Million
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $592,600 - $966,200	20,000 Added 1.67%	1,218,515 $40.3 Million
Q2 2022 Aug 15, 2022	BUY	$27.79 - $50.61 $4.2 Million - $7.65 Million	151,075 Added 14.42%	1,198,515 $42.2 Million
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $13.7 Million - $24.3 Million	347,014 Added 49.54%	1,047,440 $48.2 Million
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $10 Million - $14.2 Million	172,500 Added 32.68%	700,426 $46.4 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $5.55 Million - $8.07 Million	95,000 Added 21.94%	527,926 $33 Million
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $1.55 Million - $2.26 Million	25,000 Added 6.13%	432,926 $35.9 Million
Q1 2021 May 17, 2021	BUY	$61.35 - $90.47 $2.58 Million - $3.8 Million	42,000 Added 11.48%	407,926 $27.1 Million
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $6.9 Million - $13.4 Million	-157,489 Reduced 30.09%	365,926 $28.1 Million
Q3 2020 Nov 16, 2020	SELL	$33.21 - $51.27 $1.32 Million - $2.04 Million	-39,876 Reduced 7.08%	523,415 $22.5 Million
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $3.31 Million - $5.49 Million	126,777 Added 29.04%	563,291 $24.3 Million
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $8.97 Million - $27.6 Million	436,514 New	436,514 $12.6 Million
Q3 2019 Nov 14, 2019	SELL	$26.26 - $34.86 $14.6 Million - $19.4 Million	-557,455 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$17.43 - $28.82 $7.41 Million - $12.2 Million	-425,000 Reduced 43.26%	557,455 $14.8 Million
Q1 2019 May 15, 2019	SELL	$12.05 - $20.18 $993,799 - $1.66 Million	-82,473 Reduced 7.74%	982,455 $18 Million
Q4 2018 Feb 14, 2019	BUY	$10.74 - $19.7 $11.4 Million - $21 Million	1,064,928 New	1,064,928 $13.2 Million

Others Institutions Holding ARWR

# of Institutions

291

Shares Held

91.6M

Call Options Held

1.33M

Put Options Held

549K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.12B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquilo Capital Management, LLC with notifications on news.

Account

Aquilo Capital Management, LLC Arrowhead Pharmaceuticals, Inc. Transaction History